Autoimmune Diseases Working Party (ADWP)
Study type:
Study number:
2005-003337-40
Type of treatment:
Diseases:
Auto immune disorders
Short title:
ASTIC
Primary objective:
To evaluate the potential clinical benefit of hematopietic stem cell mobilisation by high dose immunoablation and autologous stem cell transplantation versus hematopoietic stem cell mobilisation only followed by best clinical practice in patients with Crohn's disease
Key inclusion criteria:
18-50 years old
Country:
United Kingdom
France
Czech Republic
Germany
Italy
Spain
Switzerland
Canada
Principal investigator:
Christopher J Hawkey
EBMT Study coordinator:
Janette Zarev